These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 30938547)
1. Population pharmacokinetics and dosing regimen optimization of tacrolimus in Chinese pediatric hematopoietic stem cell transplantation patients. Wang D; Chen X; Xu H; Li Z Xenobiotica; 2020 Feb; 50(2):178-185. PubMed ID: 30938547 [TBL] [Abstract][Full Text] [Related]
2. Initial Dosage Optimization of Tacrolimus in Pediatric Patients With Thalassemia Major Undergoing Hematopoietic Stem Cell Transplantation Based on Population Pharmacokinetics. Zhou S; Zhang R; Lv C; Lu J; Wei Y; Li C; Chen M; Li Q; Liu T Ann Pharmacother; 2021 Apr; 55(4):440-451. PubMed ID: 32924532 [TBL] [Abstract][Full Text] [Related]
3. Model extrapolation to a real-world dataset: evaluation of tacrolimus population pharmacokinetics and drug interaction in pediatric liver transplantation patients. Wang DD; Chen X; Fu M; Zheng QS; Xu H; Li ZP Xenobiotica; 2020 Apr; 50(4):371-379. PubMed ID: 31192749 [TBL] [Abstract][Full Text] [Related]
4. Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach. Yang S; Wei J; Pan X; Li Z; Zhang X; Li Z; Dong X; Hua Z; Li X Eur J Clin Pharmacol; 2024 Sep; 80(9):1409-1420. PubMed ID: 38904798 [TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetic analysis and dosing guidelines for tacrolimus co-administration with Wuzhi capsule in Chinese renal transplant recipients. Jing Y; Kong Y; Hou X; Liu H; Fu Q; Jiao Z; Peng H; Wei X J Clin Pharm Ther; 2021 Aug; 46(4):1117-1128. PubMed ID: 33768546 [TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. Wang DD; Lu JM; Li Q; Li ZP J Clin Pharm Ther; 2018 Aug; 43(4):476-483. PubMed ID: 29766530 [TBL] [Abstract][Full Text] [Related]
7. Population pharmacokinetics and dosage optimization of tacrolimus in pediatric patients with nephrotic syndrome . Wang X; Han Y; Chen C; Ma L; Xiao H; Zhou Y; Cui Y; Wang F; Su B; Yao Y; Ding J Int J Clin Pharmacol Ther; 2019 Mar; 57(3):125-134. PubMed ID: 30663980 [TBL] [Abstract][Full Text] [Related]
8. Wuzhi capsule and haemoglobin influence tacrolimus elimination in paediatric kidney transplantation patients in a population pharmacokinetics analysis: A retrospective study. Wang DD; Chen X; Li ZP J Clin Pharm Ther; 2019 Aug; 44(4):611-617. PubMed ID: 30864229 [TBL] [Abstract][Full Text] [Related]
9. [Population pharmacokinetic study of tacrolimus in patients with hematopoietic stem cell transplant]. Xue L; Rui JZ; Zhang Y; Miao LY Yao Xue Xue Bao; 2009 Oct; 44(10):1145-51. PubMed ID: 20055140 [TBL] [Abstract][Full Text] [Related]
10. Dosage optimization of tacrolimus based on the glucocorticoid dose and pharmacogenetics in adult patients with systemic lupus erythematosus. Wang CB; Zhang YJ; Zhao MM; Zhao L Int Immunopharmacol; 2023 Nov; 124(Pt A):110866. PubMed ID: 37678026 [TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of cyclosporine A based on NONMEM in Chinese allogeneic hematopoietic stem cell transplantation recipients. Zhou H; Gao Y; Cheng XL; Li ZD Eur J Drug Metab Pharmacokinet; 2012 Dec; 37(4):271-8. PubMed ID: 22446981 [TBL] [Abstract][Full Text] [Related]
12. Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogenetics. Chen X; Wang DD; Xu H; Li ZP Expert Rev Clin Pharmacol; 2020 May; 13(5):553-561. PubMed ID: 32452705 [TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in Chinese liver transplant patients. Chen B; Shi HQ; Liu XX; Zhang WX; Lu JQ; Xu BM; Chen H J Clin Pharm Ther; 2017 Dec; 42(6):679-688. PubMed ID: 28833329 [TBL] [Abstract][Full Text] [Related]
14. Population pharmacokinetic study of tacrolimus in pediatric patients with primary nephrotic syndrome: A comparison of linear and nonlinear Michaelis-Menten pharmacokinetic model. Huang L; Liu Y; Jiao Z; Wang J; Fang L; Mao J Eur J Pharm Sci; 2020 Feb; 143():105199. PubMed ID: 31862313 [TBL] [Abstract][Full Text] [Related]
15. Population pharmacokinetic analysis of tacrolimus early after Chinese pediatric liver transplantation. Yang JW; Liao SS; Zhu LQ; Zhao Y; Zhang Y; Sun XY; Rao W; Qu W; Li WZ; Sun LY Int J Clin Pharmacol Ther; 2015 Jan; 53(1):75-83. PubMed ID: 25207550 [TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation. Li TF; Hu L; Ma XL; Huang L; Liu XM; Luo XX; Feng WY; Wu CF Acta Pharmacol Sin; 2019 Dec; 40(12):1603-1610. PubMed ID: 31341257 [TBL] [Abstract][Full Text] [Related]
17. Dose tailoring of tacrolimus based on a non-linear pharmacokinetic model in children with refractory nephrotic syndrome. Li L; Zhu M; Li DY; Guo HL; Hu YH; Xu ZY; Jing X; Chen F; Zhao F; Li YM; Xu J; Jiao Z Int Immunopharmacol; 2021 Sep; 98():107827. PubMed ID: 34284341 [TBL] [Abstract][Full Text] [Related]
18. Body Surface Area-Based Dosing of Mycophenolate Mofetil in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Prospective Population Pharmacokinetic Study. Park HJ; Hong KT; Han N; Kim IW; Oh JM; Kang HJ Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140082 [TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of tacrolimus in pediatric hematopoietic stem cell transplant recipients: new initial dosage suggestions and a model-based dosage adjustment tool. Wallin JE; Friberg LE; Fasth A; Staatz CE Ther Drug Monit; 2009 Aug; 31(4):457-66. PubMed ID: 19531982 [TBL] [Abstract][Full Text] [Related]
20. Can Published Population Pharmacokinetic Models of Busulfan Be Used for Individualized Dosing in Chinese Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation? An External Evaluation. Huang H; Liu M; Ren J; Hu J; Lin S; Li D; Huang W; Chen S; Yang T; Wu X J Clin Pharmacol; 2022 May; 62(5):609-619. PubMed ID: 34695225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]